March 16, 2017

VUMC joins cutting-edge obesity research network

Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).

By Craig Boerner

July 18, 2016

Diabetes drugs may ease addiction

Drugs that are being used clinically to treat obesity and diabetes may also have a role in treating drug abuse.

By Bill Snyder

January 28, 2016

Award recognizes Niswender’s research achievements

Kevin Niswender, M.D., Ph.D., a physician-scientist at Vanderbilt University Medical Center whose work has helped advance understanding of diseases ranging from obesity to schizophrenia, is one of 10 recipients of the 2016 Harrington Scholar-Innovator Awards.

By Bill Snyder

November 20, 2014

Receptor discovery shines new light on appetite regulation

A receptor in the brain that regulates appetite and body weight has now been found in L cells, key regulatory cells in the gut, providing the pharmaceutical industry with a novel drug target for both obesity and diabetes, a Vanderbilt University-led research team reported this week.

By Bill Snyder

October 23, 2012

Vanderbilt researchers find that diabetes drug could be effective in treating addiction

A drug already used for the medical management of diabetes also reduces the rewarding effects of cocaine in animals, which could have far-reaching implications for patients worldwide who suffer from addiction.

By Craig Boerner